248 related articles for article (PubMed ID: 26497354)
21. [Recent progress in the treatment of malignant lymphoma].
Ogura M
Gan To Kagaku Ryoho; 2001 Sep; 28(9):1213-35. PubMed ID: 11579632
[TBL] [Abstract][Full Text] [Related]
22. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
[TBL] [Abstract][Full Text] [Related]
23. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
[TBL] [Abstract][Full Text] [Related]
24. Treating Hodgkin lymphoma in the new millennium: Relapsed and refractory disease.
LaCasce AS
Hematol Oncol; 2019 Jun; 37 Suppl 1():87-91. PubMed ID: 31187532
[TBL] [Abstract][Full Text] [Related]
25. Brentuximab Vedotin in Transplant-Naïve Relapsed/Refractory Hodgkin Lymphoma: Experience in 30 Patients.
Zinzani PL; Pellegrini C; Cantonetti M; Re A; Pinto A; Pavone V; Rigacci L; Celli M; Broccoli A; Argnani L; Pulsoni A
Oncologist; 2015 Dec; 20(12):1413-6. PubMed ID: 26500229
[TBL] [Abstract][Full Text] [Related]
26. Antibodies and antibody-drug conjugates in the treatment of Hodgkin lymphoma.
Eichenauer DA; Engert A
Eur J Haematol; 2014 Jul; 93(1):1-8. PubMed ID: 24750367
[TBL] [Abstract][Full Text] [Related]
27. Modern management of lymphocyte-predominant Hodgkin lymphoma.
Xing KH; Savage KJ
Br J Haematol; 2013 May; 161(3):316-29. PubMed ID: 23398605
[TBL] [Abstract][Full Text] [Related]
28. SEOM clinical guidelines for the treatment of Hodgkin's lymphoma.
Quero Blanco C; García Arroyo R; Provencio Pulla M; Rueda Domínguez A; Isla Casado D;
Clin Transl Oncol; 2010 Nov; 12(11):753-9. PubMed ID: 20974568
[TBL] [Abstract][Full Text] [Related]
29. Novel agents for the treatment of Hodgkin lymphoma.
Dumaswala K; Mehta A
Expert Rev Hematol; 2015 Oct; 8(5):659-67. PubMed ID: 26343891
[TBL] [Abstract][Full Text] [Related]
30. Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.
Hoppe RT; Advani RH; Ai WZ; Ambinder RF; Aoun P; Bello CM; Benitez CM; Bernat K; Bierman PJ; Blum KA; Chen R; Dabaja B; Forero A; Gordon LI; Hernandez-Ilizaliturri FJ; Hochberg EP; Huang J; Johnston PB; Kaminski MS; Kenkre VP; Khan N; Maloney DG; Mauch PM; Metzger M; Moore JO; Morgan D; Moskowitz CH; Mulroney C; Poppe M; Rabinovitch R; Seropian S; Smith M; Winter JN; Yahalom J; Burns J; Ogba N; Sundar H
J Natl Compr Canc Netw; 2017 May; 15(5):608-638. PubMed ID: 28476741
[TBL] [Abstract][Full Text] [Related]
31. Stem cell transplantation in Hodgkin lymphoma.
Reddy NM; Perales MA
Hematol Oncol Clin North Am; 2014 Dec; 28(6):1097-112. PubMed ID: 25459181
[TBL] [Abstract][Full Text] [Related]
32. Classical Hodgkin's lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up.
Brusamolino E; Bacigalupo A; Barosi G; Biti G; Gobbi PG; Levis A; Marchetti M; Santoro A; Zinzani PL; Tura S
Haematologica; 2009 Apr; 94(4):550-65. PubMed ID: 19278966
[TBL] [Abstract][Full Text] [Related]
33. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
34. [High dose chemoradiotherapy with autologous hemotopoietic stem cell transplantation for treatment of patients with advanced Hodgkin's lymphoma: a report of 11 cases].
Zhou SY; Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou AP; Feng FY
Ai Zheng; 2002 Apr; 21(4):405-8. PubMed ID: 12452021
[TBL] [Abstract][Full Text] [Related]
35. High-dose therapy followed by stem cell transplantation in Hodgkin's lymphoma: past and future.
Isidori A; Piccaluga PP; Loscocco F; Guiducci B; Barulli S; Ricciardi T; Picardi P; Visani G
Expert Rev Hematol; 2013 Aug; 6(4):451-64. PubMed ID: 23991931
[TBL] [Abstract][Full Text] [Related]
36. Seom guidelines for the treatment of gastric cancer 2015.
Martin-Richard M; Custodio A; García-Girón C; Grávalos C; Gomez C; Jimenez-Fonseca P; Manzano JL; Pericay C; Rivera F; Carrato A
Clin Transl Oncol; 2015 Dec; 17(12):996-1004. PubMed ID: 26691658
[TBL] [Abstract][Full Text] [Related]
37. Biliary tract cancers: SEOM clinical guidelines.
Benavides M; Antón A; Gallego J; Gómez MA; Jiménez-Gordo A; La Casta A; Laquente B; Macarulla T; Rodríguez-Mowbray JR; Maurel J
Clin Transl Oncol; 2015 Dec; 17(12):982-7. PubMed ID: 26607930
[TBL] [Abstract][Full Text] [Related]
38. Guidelines for the investigation and management of nodular lymphocyte predominant Hodgkin lymphoma.
McKay P; Fielding P; Gallop-Evans E; Hall GW; Lambert J; Leach M; Marafioti T; McNamara C;
Br J Haematol; 2016 Jan; 172(1):32-43. PubMed ID: 26538004
[No Abstract] [Full Text] [Related]
39. What is the role of autologous transplant for lymphoma in the current era?
Stiff P
Hematology Am Soc Hematol Educ Program; 2015; 2015():74-81. PubMed ID: 26637704
[TBL] [Abstract][Full Text] [Related]
40. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
